Kim Appleton

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors

Kim Appleton, Helen Mackay, Ian Judson et al. · Journal of Clinical Oncology · 2007 · 229 citations · Full text

Medicine, Oncology, Pharmacology +16

Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes

Gordon Strathdee, Kim Appleton, Maureen Illand et al. · American Journal Of Pathology · 2001 · 203 citations

Medicine, Molecular Genetics, Oncology +10

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer

Rosalind Glasspool, Robert Brown, Martin Gore et al. · British Journal of Cancer · 2014 · 123 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial

Andrew Jahoda, Richard P. Hastings, Chris Hatton et al. · The Lancet Psychiatry · 2017 · 84 citations · Full text

Education, Psychiatry, Psychology +13

Multiple cysteine proteinases of the pathogenic protozoon Tritrichomonas foetus: identification of seven diverse and differentially expressed genes

David J. Mallinson, Julie Livingstone, Kim Appleton et al. · Microbiology · 1995 · 34 citations

Life Sciences, Biology, Microbiology +9